Socio-demographic and cognition variables https://figshare.com/s/a9b7606c8ef68f9253fd.

<p>Socio-demographic and cognition variables <a href="https://figshare.com/s/a9b7606c8ef68f9253fd" target="_blank">https://figshare.com/s/a9b7606c8ef68f9253fd</a>.</p

Associations between white noise speech illusion and SIS-R and CAPE https://figshare.com/s/09c048d70d0c4ef3ed0c.

<p>Associations between white noise speech illusion and SIS-R and CAPE <a href="https://figshare.com/s/09c048d70d0c4ef3ed0c" target="_blank">https://figshare.com/s/09c048d70d0c4ef3ed0c</a>.</p

Socio-demographic variables.

<p>Socio-demographic variables.</p

Comparison of the percentage of correct answers for emotion recognition in FEP, BPD and HC.

<p>Unadjusted and adjusted analyses.</p

Comparison of the percentage of subjects’ attribution when they failed in FEP, BPD and HC.

<p>Unadjusted and adjusted analyses.</p

Clinical variables.

<p>Clinical variables.</p

Association between jumping to conclusions (beads<1) and the group variable reflecting psychosis liability (linear trend and as 2 dummy variables compared with control group).

<p>PL = psychosis liability, Group = 0: controls; group = 1: BPD; group = 2: FEP</p><p>^a adjusted for age, gender, years of education and use of cannabis</p><p>^b adjusted for general intelligence</p><p>^c adjusted for age, gender, years of education, use of cannabis and general intelligence</p><p>Association between jumping to conclusions (beads<1) and the group variable reflecting psychosis liability (linear trend and as 2 dummy variables compared with control group).</p

Association between JTC and positive symptoms in patients with FEP.

<p>^a calculated with JTC and 1 symptom domain at the time.</p><p>^b calculated with JTC and all symptom domains entered simultaneously.</p><p>Association between JTC and positive symptoms in patients with FEP.</p

Clinical variables.

<p>FEP FU: first episode psychosis at one year follow-up. 44% of FEP displayed jumping to conclusions (one draw before taking a decision) vs 9% of controls and 19% of BPD patients (p<0.0001).</p><p>Clinical variables.</p